A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxorubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node-Negative Triple-Negative Invasive Breast Cancer

Type of Cancer
Breast Oncology

Site
Hackensack

Sponsor
NRG

Protocol Number
NRG Oncology BR003

To Learn More Call
201-510-0910